Pharmaron Beijing Co., Ltd. (SHE:300759)

Market Cap	50.14B
Revenue (ttm)	13.54B
Net Income (ttm)	1.51B
Shares Out	1.77B
EPS (ttm)	0.86
PE Ratio	34.94
Forward PE	24.12
Dividend	0.20 (0.67%)
Ex-Dividend Date	Jul 4, 2025

Volume	34,843,000
Average Volume	15,476,481
Open	29.03
Previous Close	29.05
Day's Range	28.87 - 30.12
52-Week Range	20.47 - 37.63
Beta	1.16
RSI	50.67
Earnings Date	Mar 26, 2026

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotide...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 21,370
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300759

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.